Balance Sheet for Abbott Laboratories (ABT)

$ 107.79   -1.69 (-1.54%) Volume: 3.57m 4:02 PM EDT 23-Oct-2020
After Hours:  $ 108.50   0.71 (+0.66%) Volume: 363.18k 7:56 PM EDT 23-Oct-2020
Statement: View:
Assets [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 3,860 3,844 9,407 18,620 5,001
Restrictable Cash - - - - -
Marketable Securities 280 242 203 155 1,124
Accounts Receivable 5,425 5,182 5,249 3,248 3,418
Loans Receivable - - - - -
Other Receivables 5,579 5,237 - - -
Receivables 5,425 5,182 5,249 3,248 3,418
Inventories, Raw Materials 972 890 790 516 539
Inventories, Work in Progress 560 499 472 294 316
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 2,784 2,407 2,339 1,624 1,744
Inventories, Other 4,316 3,796 3,601 2,434 2,599
Inventories, Adjustments & Allowances - - - - -
Inventories 4,316 3,796 3,601 2,434 2,599
Prepaid Expenses 1,786 1,568 1,667 1,806 1,908
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 15,667 14,632 20,147 26,776 14,155
Land and Improvements 519 501 526 408 432
Buildings and Improvement 3,702 3,555 3,613 2,602 2,769
Machinery, Furniture and Equipment 11,468 10,756 10,394 8,394 8,254
Construction in Progress 1,110 894 732 962 928
Fixed Assets, Other - - - - -
Fixed Assets, Total 16,799 15,706 15,265 12,366 12,383
Gross Fixed Assets 16,799 15,706 15,265 12,366 12,383
Accumulated Depreciation (8,761) (8,143) (7,658) (6,661) (6,653)
Net Fixed Assets 8,038 7,563 7,607 5,705 5,730
Intangibles 17,025 18,942 21,473 4,539 5,562
Cost in Excess 23,195 23,254 24,020 7,683 9,638
Non-Current Deferred Income Taxes 3,079 1,885 1,944 2,263 2,119
Other Non-Current Assets - 17 176 2,753 2
Total Non-Current Assets 52,220 52,541 56,103 25,890 27,092
Total Assets 67,887 67,173 76,250 52,666 41,247
Liabilities [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 3,464 3,141 2,526 1,288 1,221
Short Term Debt 1,478 207 714 1,325 3,130
Notes Payable - - - - -
Accrued Expenses 5,060 4,796 4,874 3,223 3,649
Accrued Liabilities 5,060 4,796 4,874 3,223 3,649
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 861 868 798 824 1,186
Total Current Liabilities 10,863 9,012 8,912 6,660 9,186
Long Term Debt 16,661 19,359 27,210 20,681 5,871
Deferred Income Tax 1,546 2,056 2,006 356 808
Other Non-Current Liabilities 6,761 6,024 7,024 4,252 4,056
Minority Interest 213 198 201 179 115
Capital Lease Obligations 755 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 25,936 27,637 36,441 25,468 10,850
Total Liabilities 36,799 36,649 45,353 32,128 20,036
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 31,088 30,524 30,897 20,538 21,211
Common Par 23,853 23,512 23,206 - -
Additional Paid in Capital - - - 13,027 12,734
Cumulative Translation Adjustments - - - - -
Retained Earnings 25,847 24,560 23,978 25,565 25,757
Treasury Stock 10,147 9,962 10,225 10,791 10,622
Other Equity Adjustments (8,465) (7,586) (6,062) (7,263) (6,658)
Total Capitalization 47,749 49,883 58,107 41,219 27,082
Total Equity 31,088 30,524 30,897 20,538 21,211
Total Liabilities & Shareholder's Equity 67,887 67,173 76,250 52,666 41,247
Cash Flow 3,687 2,368 477 1,400 4,423
Working Capital 4,804 5,620 11,235 20,116 4,969
Free Cash Flow 4,498 4,906 4,435 2,082 1,856
Invested Capital 47,749 49,883 58,107 41,219 27,082
Shares Outstanding - Common Class Only 1,763 1,756 1,744 1,473 1,473
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 1,763 1,756 1,744 1,473 1,473
Total Common Shares Outstanding 1,763 1,756 1,744 1,473 1,473
Treasury Shares 214 216 222 235 229
Basic Weighted Shares Outstanding 1,768 1,758 1,740 1,477 1,496
Diluted Weighted Shares Outstanding 1,781 1,770 1,749 1,483 1,506